Efficacy of Colchicine Prophylaxis in Gout (1961)

Article1 August 1961Efficacy of Colchicine Prophylaxis in GoutPrevention of Recurrent Gouty Arthritis Over a Mean Period of Five Years in 208 Gouty SubjectsTS'AI FAN YÜ, M.D., ALEXANDER B. GUTMAN, M.D., F.A.C.P.TS'AI FAN YÜ, M.D.Search for more papers by this author, ALEXANDER B. GUTMAN, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-55-2-179 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptOver the centuries and into the present era, innumerable regimens have been proposed for prevention of recurrence of acute attacks in the intercritical period of gout. These alleged preventives include an extraordinary assortment of diets, drugs, lotions, and waters, to say nothing of bizarre manipulations (such as acupuncture) apparently derived from ancient ritualistic practices. Each proposal in turn has had its coterie of claimants but none has stood the test of time except, perhaps, for the qualified success of dietary restriction of purines, proteins, and fats.Curiously enough, until comparatively recently there has been only occasional passing reference in the...References1. COHEN A: Gout. Amer. J. Med. Sci. 192: 488, 1936. CrossrefGoogle Scholar2. COHEN A: Gout among arthritics. Penn. Med. J. 41: 1100, 1938. Google Scholar3. TALBOTTCOOMBS JHFS: Metabolic studies on patients with gout. J. A. M. A. 110: 1977, 1938. CrossrefGoogle Scholar4. TALBOTT JH: Gout, Oxford University Press, New York, 1943. Google Scholar5. GUTMAN AB: Some recent advances in the study of uric acid metabolism and gout. Bull. N. Y. Acad. Med. 27: 144, 1951. MedlineGoogle Scholar6. GUTMANYÜ ABTF: Current principles of management in gout. Amer. J. Med. 13: 744, 1952. CrossrefMedlineGoogle Scholar7. TALBOTT JH: Gout, Grune & Stratton, New York, 1957. Google Scholar8. ROBINSON WD: Current status of the treatment of gout. J. A. M. A. 164: 1670, 1957. CrossrefMedlineGoogle Scholar9. RHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS. (Thirteenth Rheumatism Review): Gout and gouty arthritis. Ann. Intern. Med. 53: 119, 1960. Google Scholar10. RHEUMATISM AND ARTHRITIS: REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS. (Twelfth Rheumatism Review): Gout and gouty arthritis. Ann. Intern. Med. 50: 470, 1959. Google Scholar11. GOODMANGILMAN LSA: The Pharmacological Basis of Therapeutics, The Macmillan Company, New York, 1955. Google Scholar12. WALLACE SL: Colchicine. Clinical pharmacology in acute gouty arthritis. Amer. J. Med. 30: 439, 1961. CrossrefMedlineGoogle Scholar13. SHANBROMRAPOPORT EL: Gastrointestinal complications of colchicine therapy in gout. Ann. Intern. Med. 48: 655, 1958. LinkGoogle Scholar14. KUZELLSCHAFFARZICKNAUGLERKOETSMANKLEBROWNCHAMPLIN WCRWWEPEABB: Some observations on 520 gouty patients. J. Chron. Dis. 2: 645, 1955. CrossrefMedlineGoogle Scholar15. SMYTHHUFFMANWILSON CJERGM: Treatment of gout. Arch. Intern. Med. 97: 783, 1956. CrossrefGoogle Scholar16. RUIZ MORENO A: Prevensión de los ataques gotosos por la fenilbutazona. Arch. Argent. Reum. 10: 188, 1956. Google Scholar17. RUIZ MORENO A: Profilaxis de los ataques gotosos por medio de la fenilbutazona. Arch. Argent. Reum. 23: 21, 1960. Google Scholar18. DE SEZERYCKEWAERTLEVERNIEUXMARTEAU SAJR: Physiopathology, clinical manifestations, and treatment of gout. Part 2. Clinical and therapeutic studies. Ann. Rheum. Dis. 17: 15, 1958. CrossrefMedlineGoogle Scholar19. GRAHAM W: The status of phenylbutazone (Butazolidin) in the treatment of rheumatic disorders. Canad. Med. Ass. J. 79: 634, 1958. MedlineGoogle Scholar20. SMYTHFRANKHUFFMAN CJLSER: Urate diuretic therapy in chronic gout. A.I.R. 3: 3, 1960. Google Scholar21. BARTELS EC: Successful treatment of gout. Ann. Intern. Med. 18: 21, 1943. LinkGoogle Scholar22. BARTELSMATOSSIAN ECGS: Gout: six year follow-up on probenecid (Benemid) therapy. Arthritis Rheum. 2: 193, 1959. CrossrefMedlineGoogle Scholar23. TALBOTT JH: The choice of a uricosuric agent in gout. Arthritis Rheum. 2: 182, 1959. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: TS'AI FAN YÜ, M.D.; ALEXANDER B. GUTMAN, M.D., F.A.C.P.Affiliations: New York, N. Y.Received for publication April 24, 1961.From the Department of Medicine, The Mount Sinai Hospital, New York, N. Y.This work was supported in part by a grant-in-aid (A-162) from the National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, U. S. Public Health Service, Department of Health, Education, and Welfare.Requests for reprints should be addressed to Alexander B. Gutman, M.D., Director, Department of Medicine, The Mount Sinai Hospital, Fifth Avenue and One Hundredth Street, New York 29, N. Y. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byTsai-Fan Yu: physician and researcher who established modern gout managementSystemic and Localized Inflammatory Diseases of Older AdultsGoutProphylaxis of Acute Arthritis at Initiation of Urate-Lowering Therapy in Gout PatientsUrate-lowering treatment and risk of total joint replacement in patients with goutMiscellaneous Drugs and Male ReproductionClinical Features and Treatment of GoutColchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulationSalivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathyThrombocytopenia due to low-dose colchicine therapy: A possible drug interaction with nivolumab and implications for supportive careRising burden of gout in the UK but continuing suboptimal management: a nationwide population studyEpidemiology and management of gout in Taiwan: a nationwide population studyThe impact of familial Mediterranean fever on reproductive systemRhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney diseasePrevention and Treatment of Inflammation in GoutAllopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012Clinical Features and Treatment of GoutLatest evidence on gout management: what the clinician needs to knowTreatment of Chronic Gouty Arthritis: It Is Not Just About Urate-Lowering TherapyMetabolite target analysis of human urine combined with pattern recognition techniques for the study of symptomatic goutRisk factors for gout and prevention: a systematic review of the literatureManagement of pericardial diseases during pregnancyFebuxostat: A selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with goutGout and HyperuricemiaManagement of goutManagement of Gout in Older AdultsDiscussion Following Cases 4 and 5Case 6: Maintenance Therapy for Simple Intermittent GoutGout: can we create an evidence-based systematic approach to diagnosis and management?Clinical Trials in Crystal ArthropathySuccessful treatment of chronic tophaceous gout with infliximab (Remicade)Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutDiagnosis and management of gout: a rational approachFebuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with goutColchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiationThe outcome of pregnancy in the wives of men with familial mediterranean fever treated with colchicineManagement of Acute and Chronic Gouty ArthritisArthritis and related diseases of the foot and ankle: rehabilitation and biomechanical considerationsThe management of hyperuricemia and gout in patients with heart failureGout RemediesOptimisation of the Treatment of Acute GoutDiagnosis and Treatment of Gout in the Intensive Care UnitThe Management of GoutEffects of Colchicine on IgE-Mediated Early and Late Airway ReactionsTREATMENT OF REFRACTORY CRYSTAL-ASSOCIATED ARTHRITISEffect of long-term colchicine therapy on jejunal mucosaGout and HyperuricemiaColchicine intoxication: Clinical pharmacology, risk factors, features, and managementColchicine prophylaxis in familial Mediterranean fever: Reappraisal after 15 yearsCrystal-associated arthropathiesGout and HyperuricemiaControl of Crystal-Induced ArthropathiesDiet and Drug Treatment of GoutTherapy in GoutEvaluation of colchicine therapy in primary biliary cirrhosisURATE METABOLISM AND GOUT - A PERSPECTIVEThe Effects of Long-term Colchicine Therapy on Male Fertility in Patients with Familial Mediterranean FeverGout and other crystal-deposition disordersDrug therapy (3): ‘specific’ drugsThe efficacy of colchicine prophylaxis in articular gout—A reappraisal after 20 yearsGastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever)Treatment of Hyperuricemia and GoutDrug Treatment of GoutManagement of GoutPETER A. SIMKIN, M.D.Testicular Function in Patients with Familial Mediterranean Fever on Long-Term Colchicine TreatmentAcquired Causes of HyperuricaemiaPharmacology of Drugs Used in Treatment of Acute GoutThe Treatment of The Acute Attack of GoutUnderstanding GoutRadioimmunoassay for Colchicine in Plasma and UrineColchicine and Testicular Function in ManDauertherapieDie Therapie des GichtanfallesClinical experiencesBehandlung der GichtProphylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patientsColchicineThe Past Four Decades of Progress in the Knowledge of Gout, With an Assessment of the Present StatusThe treatment of goutTHE MANAGEMENT OF GOUTBone marrow depression associated with acute colchicine toxicity in the presence of hepatic dysfunctionMalignant Gout with Tophaceous Small Intestine and Megaloblastic AnaemiaGoutRheumatism and Arthritis Review of American and English Literature of Recent Years (Sixteenth Rheumatism Review)CHARLEY J. SMYTH, M.D., F.A.C.P., ROGER L. BLACK, M.D., CHARLES CHRISTIAN, M.D., MACK L. CLAYTON, M.D., F.A.C.S., DONALD F. HILL, M.D., F.A.C.P., JOSEPH LEE HOLLANDER, M.D., F.A.C.P., WILLIAM M. MIKKELSEN, M.D., F.A.C.P., MAX M. MONTGOMERY, M.D., F.A.C.P., CARL M. PEARSON, M.D., F.A.C.P., HUGH A. SMYTHE, M.D., F.R.C.P. (C), L. EMMERSON WARD, M.D., F.A.C.P., HOWARD J. WEINBERGER, M.D., F.A.C.P.A COMPARISON OF URICOSURIC AGENTS IN GOUT, WITH SPECIAL REFERENCE TO SULPHINPYRAZONE 1 August 1961Volume 55, Issue 2 Page: 179-192 Keywords Arthritis Genetics Gout Hospital medicine Medical services Metabolic disorders Prevention, policy, and public health Prophylaxis Proteins Purines ePublished: 1 December 2008 Issue Published: 1 August 1961 Copyright & PermissionsCopyright ©, 1961, by The American College of PhysiciansPDF downloadLoading ...